If they (Zacks) don't give a reason, then they are unworthy. IBD is better indicator. 5-day candlestick chart shows that we could be moving higher very soon. We have seen negative posts all the way up at various resistance levels all the way to $13. Those shorts were forced to move on (most recently anotherenigma said $9's would not hold, and KABOOM happened on him; now no more posting from enigma). We will see $15. This stock is stronger than you think. I maintain my rating.
It's not my rating its ZACKS I'am long on snts but I pay ZACKS $199 per year and they have made me thousands with their research. They are not always right and they don't claim to be but more times than not they are. Nothing wrong with IBD but they are not always right either. It seems that Zacks estimates SNTS earnings are going to fall in the coming quarters. Bio-techs are very hard to follow, their PPS is all over the place. Staying long just not adding.